According to our latest research, the global Central Nervous System (CNS) Biomarkers Market size reached USD 6.32 billion in 2024, reflecting a robust growth trajectory. The market is projected to expand at a CAGR of 9.1% from 2025 to 2033, culminating in a forecasted market size of USD 14.2 billion by 2033. This remarkable growth is primarily driven by the rising prevalence of neurological disorders, increasing investments in biomarker research, and the growing adoption of precision medicine in clinical practice worldwide. https://growthmarketreports.com/report/central-nervous-system-biomarkers-market-global-industry-analysis